<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Preprints on Booster Timeline</title><link>https://democracy.paulromer.net/preprint/</link><description>Recent content in Preprints on Booster Timeline</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Sat, 21 Aug 2021 00:00:00 +0000</lastBuildDate><atom:link href="https://democracy.paulromer.net/preprint/index.xml" rel="self" type="application/rss+xml"/><item><title>Mayo Clinic Study</title><link>https://democracy.paulromer.net/preprint/mayo_study/</link><pubDate>Sat, 21 Aug 2021 00:00:00 +0000</pubDate><guid>https://democracy.paulromer.net/preprint/mayo_study/</guid><description>&amp;hellip; effectiveness against infection was lower for both vaccines (mRNA-1273: 76%, 95% CI: 58-87%; BNT162b2: 42%, 95% CI: 13-62%)</description></item><item><title>Humoral immune response in inactivated SARS-CoV-2 vaccine: When should a booster dose be administered?</title><link>https://democracy.paulromer.net/preprint/vaccine-efficacy-study-when-should-booster-be-admin/</link><pubDate>Tue, 13 Jul 2021 00:00:00 +0000</pubDate><guid>https://democracy.paulromer.net/preprint/vaccine-efficacy-study-when-should-booster-be-admin/</guid><description>Antibody concentrations after vaccination with two doses were found to be decreased. A booster at months 6-12 is recommended for the inactive SARS-CoV-2 vaccination.</description></item></channel></rss>